Severe Outcomes From Suspected Human Parvovirus B19 Infection in Immunocompetent Children: The Need for Timely...

Area of Science:

• Pediatrics
• Infectious Diseases
• Cardiology

Background:

• Human Parvovirus B19 (PVB19) is a common virus, typically causing mild illness.
• Recent observations suggest a potential increase in the severity of PVB19 infections.
• Previously healthy children are not typically considered at high risk for severe PVB19 outcomes.

Purpose of the Study:

• To report a cluster of severe outcomes in children due to suspected PVB19 infection.
• To describe the clinical presentations and management of these severe cases.
• To emphasize the need for reassessing PVB19 risks in pediatric populations.

Main Methods:

• Retrospective case series of 13 children presenting to a Level III Pediatric Hospital.
• Clinical data collection including diagnosis, treatment, and outcomes.
• Laboratory confirmation of PVB19 viremia in affected patients.

Main Results:

• Seven cases of myocarditis, one acute myocardial infarction, two encephalitis, one meningitis, one pancreatitis, and one pancytopenia were identified.
• Four children required extracorporeal membrane oxygenation (ECMO).
• One patient died from cardiac shock; two others required mechanical circulatory support and are awaiting transplantation.

Conclusions:

• PVB19 can cause severe, life-threatening illness in previously healthy children.
• Proactive surveillance for emerging and reemerging pathogens like PVB19 is crucial.
• The risk profile for severe PVB19 infection may need reevaluation in pediatric populations.